Tvardi Therapeutics (69C.F) Q3 2024 Earnings

14AugConfirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-0.52
-0.43
-0.34
-0.25

Details

Expected EPS
-0.24879200000000004
Actual EPS
-0.24516000000000002
Surprise EPS
0
Surprise Percent
+1.46%

Description

Tvardi Therapeutics (69C.F) has reported earnings of -0.24516000000000002 per share for Q3 2024.

0 Comments

Share your thoughts